POLIANI, Pietro Luigi
 Distribuzione geografica
Continente #
NA - Nord America 8.911
EU - Europa 2.941
AS - Asia 2.175
OC - Oceania 12
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 5
Totale 14.062
Nazione #
US - Stati Uniti d'America 8.886
CN - Cina 1.162
UA - Ucraina 950
DE - Germania 421
SG - Singapore 397
IT - Italia 376
PL - Polonia 363
HK - Hong Kong 310
FI - Finlandia 270
GB - Regno Unito 185
IE - Irlanda 172
TR - Turchia 149
FR - Francia 86
IN - India 82
BE - Belgio 26
SE - Svezia 24
CA - Canada 21
CZ - Repubblica Ceca 18
IR - Iran 16
VN - Vietnam 15
RU - Federazione Russa 14
AU - Australia 11
ID - Indonesia 10
NL - Olanda 10
EU - Europa 7
JP - Giappone 7
CL - Cile 5
TW - Taiwan 5
AT - Austria 4
GR - Grecia 4
BR - Brasile 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AM - Armenia 2
CH - Svizzera 2
EE - Estonia 2
ES - Italia 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
MU - Mauritius 2
SA - Arabia Saudita 2
TH - Thailandia 2
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BY - Bielorussia 1
CO - Colombia 1
DK - Danimarca 1
FK - Isole Falkland (Malvinas) 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
Totale 14.062
Città #
Fairfield 1.407
Woodbridge 1.143
Houston 757
Jacksonville 696
Ashburn 650
Seattle 567
Ann Arbor 556
Cambridge 527
Wilmington 476
Warsaw 363
Chandler 356
Princeton 310
Hong Kong 305
Singapore 305
Nanjing 227
Beijing 210
New York 191
Dublin 171
Helsinki 154
Istanbul 136
Brescia 129
Dearborn 106
Nanchang 95
Shenyang 76
San Diego 72
Des Moines 71
Hebei 68
Jinan 64
Changsha 63
Shanghai 56
Milan 48
Tianjin 46
Lancaster 35
Jiaxing 34
London 31
Verona 27
Brussels 26
Hangzhou 26
Ningbo 26
San Francisco 26
Haikou 22
San Mateo 22
Taizhou 22
Boardman 21
Zhengzhou 20
Kunming 19
Kilburn 16
Los Angeles 16
Toronto 16
Brno 15
Lanzhou 15
Munich 15
Washington 14
Ardabil 12
Dong Ket 12
Leawood 12
Pune 12
Salerno 12
Guangzhou 11
Norwalk 11
Jakarta 10
Taiyuan 10
Hounslow 9
Changchun 8
Falls Church 8
Kocaeli 8
Augusta 7
Melbourne 7
Orange 7
Romola 7
Chicago 6
Roccafranca 6
Tokyo 6
Vignate 6
Rome 5
St Louis 5
Wuhan 5
Berlin 4
Calvisano 4
Espoo 4
Gunzenhausen 4
Islington 4
Lappeenranta 4
Monmouth Junction 4
New Bedfont 4
Phoenix 4
Redwood City 4
Santa Clara 4
West Jordan 4
Amsterdam 3
Chiswick 3
Hefei 3
Naples 3
Portland 3
Treviglio 3
Vienna 3
Acton 2
Almere Stad 2
Amman 2
Atlanta 2
Totale 11.144
Nome #
MURC/cavin-4 is co-expressed with Caveolin-3 in rhabdomyosarcoma tumors and its silencing prevents myogenic differentiation in the human embryonal RD cell line 280
TREM2 sustains microglial expansion during aging and response to demyelination 220
Hypomorphic mutation in the RAG2 gene affects dendritic cell distribution and migration. 198
Tuberous sclerosis complex-associated CNS abnormalities depend on hyperactivation of mTORC1 and Akt 169
Caveolin-1, Caveolin-2 and Cavin-1 are strong predictors of adipogenic differentiation in human tumors and cell lines of liposarcoma 160
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 156
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 151
Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage 149
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 149
MURC/cavin-4 is co-expressed with Caveolin-3 in rhabdomyosarcoma tumors and its silencing prevents myogenic differentiation in the human embryonal RD cell line 147
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma 144
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma. 144
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 143
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation 141
FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration 141
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 140
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma 137
Caveolin 1 is a marker of poor differentiation in Rhabdomyosarcoma 130
EXTL3 mutations cause skeletal dysplasia, immune deficiency, and developmental delay 130
Gene Signatures Associated with Mouse Postnatal Hindbrain Neural Stem Cells and Medulloblastoma Cancer Stem Cells Identify Novel Molecular Mediators and Predict Human Medulloblastoma Molecular Classification 127
MiR-135a Inhibits Cancer Stem Cell-Driven Medulloblastoma Development by Directly Repressing Arhgef6 Expression 122
Central nervous system marginal zone B-cell lymphoma associated with Chlamydophila psittaci infection 121
Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID 120
CCRL2 regulates M1/M2 polarization during EAE recovery phase 119
Absence of Rac1 and Rac3 GTPases in the nervous system hinders thymic, splenic and immune-competence development 116
CAVEOLIN-1 IS A MARKER OF POOR DIFFERENTIATION IN RHABDOMYOSARCOMA 116
A novel brain tumour model in zebrafish reveals the role of YAP activation in MAPK- and PI3K-induced malignant growth 114
Beta-Galactosylceramidase deficiency: neurovascular implications 113
Recombination-activating gene 1 (Rag1)-deficient mice with severe combined immunodeficiency treated with lentiviral gene therapy demonstrate autoimmune Omenn-like syndrome 112
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 112
Enhanced SPARCL1 expression in cancer stem cells improves preclinical modeling of glioblastoma by promoting both tumor infiltration and angiogenesis 112
Glioblastoma models driven by different mutations converge to the proneural subtype 112
A key regulatory role for histamine in experimental autoimmune encephalomyelitis: disease exacerbation in histidine decarboxylase-deficient mice 111
Abnormalities of thymic stroma may contribute to immune dysregulation in murine models of leaky severe combined immunodeficiency 109
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 109
Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients 109
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 109
Correction of Murine Rag2 Severe Combined Immunodeficiency by Lentiviral Gene Therapy Using a Codon-optimized RAG2 Therapeutic Transgene 108
A gene therapy approach to treat demyelinating diseases using non-replicative herpetic vectors engineered to produce cytokines 107
MET inhibition overcomes radiation resistance of glioblastoma stem-like cells 107
Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D3 106
Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis 105
Leucine-rich repeat containing 8A (LRRC8A) is essential for T lymphocyte development and function 105
Brain lipid composition in grey-lethal mutant mouse characterized by severe malignant osteopetrosis. 104
Targeting Notch pathway induces growth inhibition and differentiation of neuroblastoma cells 104
Leucine-rich repeat containing 8A (LRRC8A)-dependent volume-regulated anion channel activity is dispensable for T-cell development and function 104
Lentiviral-mediated gene therapy leads to improvement of B-cell functionality in a murine model of Wiskott-Aldrich syndrome 103
Abnormalities of thymic stroma may contribute to immune dysregulation in murine models of leaky severe combined immunodeficiency 103
High doses of cobalt induce optic and auditory neuropathy 103
Exacerbation of experimental autoimmune encephalomyelitis by passive transfer of IgG antibodies from a multiple sclerosis patient responsive to immunoadsorption 103
A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome 102
Critical role for prokineticin 2 in CNS autoimmunity 102
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 101
Cytokine Therapy in Immune-mediated Demyelinating Diseases of the Central Nervous System: a Novel Gene Therapy Approach 100
Defect of regulatory T cells in patients with Omenn syndrome 100
Caveolins in rhabdomyosarcoma 100
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy 100
Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas 99
Thymus Transplantation for Complete Digeorge Syndrome: European Experience 99
Expression studies in gliomas and glial cells do not support a tumor suppressor role for LGI1 98
The Different Faces of Angiogenesis in Neuroblastoma 98
The therapeutic potential of neural stem/progenitor cells in murine globoid cell leukodystrophy is conditioned by macrophage/microglia activation 97
18F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis 97
Cytokines and Immunity in Multiple Sclerosis: the Dual Signal Hypothesis 96
Thymus microenvironment in human primary immunodeficiency diseases 96
Timing of mTOR activation affects tuberous sclerosis complex neuropathology in mouse models 96
Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors 94
Intra-tumoral dendritic cells increase efficacy of peripheral vaccination by modulation of glioma microenvironment 94
Sustained Activation of mTOR Pathway in Embryonic Neural Stem Cells Leads to Development of Tuberous Sclerosis Complex-associated Lesions 94
Plurihormonal ACTH-GH Pituitary Adenoma: Case Report and Systematic Literature Review 94
Phase II study of sunitinib and irinotecan in patients with recurrent high-grade glioma (HGG) 93
Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice 92
Dexamethasone inhibits the anti-tumor effect of interleukin-4 on rat experimental gliomas 92
Human Peripheral Lymphoid Tissues Contain Autoimmune Regulator-Expressing Dendritic Cells 92
Development of Central Nervous System Autoimmunity Is Impaired in the Absence of Wiskott-Aldrich Syndrome Protein 91
Hypomorphic Rag mutations can cause destructive midline granulomatous disease 90
Homozygous DNA Ligase IV R278H Mutation in Mice Leads to Leaky Scid and Represents A Model For Human LIG4 Syndrome 90
In Vivo Chronic Stimulation Unveils Autoreactive Potential of Wiskott-Aldrich Syndrome Protein-Deficient B Cells 90
Drug inducible transgene expression in brain using a Herpes Simplex virus vector 89
Erythropoietin/erythropoietin receptor system is involved in angiogenesis in human neuroblastoma 89
Mutations in OSTM1 (grey lethal) define a particularly severe form of autosomal recessive osteopetrosis with neural involvement 89
Intestinal microbiota sustains inflammation and autoimmunity induced by hypomorphic RAG defects 89
Replication-defective Herpes Simplex virus vectors for gene transfer in vivo 88
Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice 88
Homozygous DNA ligase IV R278H mutation in mice leads to leaky SCID and represents a model for human LIG4 syndrome 88
Early defects in human T-cell development severely affect distribution and maturation of thymic stromal cells: possible implications for the pathophysiology of Omenn syndrome 88
Cavin-2 is a specific marker for detection of well-differentiated liposarcoma. 88
NK cells recognize and kill human glioblastoma cells with stem cell-like properties 87
Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient Kit(W-sh/W-sh) mice. 87
The matricellular protein SPARC supports follicular dendritic cell networking toward Th17 responses 86
High-Definition 3-Dimensional Exoscope for 5-ALA Glioma Surgery: 3-Dimensional Operative Video 86
Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells 85
The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1 85
Anti-CD3{epsilon} mAb improves thymic architecture and prevents autoimmune manifestations in a mouse model of Omenn syndrome: therapeutic implications 84
Rag defects and thymic stroma: lessons from animal models 84
Dendritic cells pulsed with glioma lysates induce immunity against syngeneic intracranial gliomas and increase survival of tumor-bearing mice 83
Schwann cells in neuroblastoma express erythropoietin 81
Constitutional de novo deletion of the FBXW7 gene in a patient with focal segmental glomerulosclerosis and multiple primitive tumors 80
Involvement of Synapsin III in the onset of Alpha-synuclein pathology in Parkinson’s Disease 79
ZAP70 deficiency in humans is associated with abnormalities of thymic stromal cells: implications for T cell tolerance 78
Totale 11.022
Categoria #
all - tutte 73.749
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.749


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.630 0 0 0 0 241 431 351 410 274 567 148 208
2020/20212.729 48 268 210 359 111 300 124 279 320 279 291 140
2021/20221.280 91 254 24 60 21 58 80 97 56 142 109 288
2022/20231.113 173 28 31 55 117 300 1 111 171 18 56 52
2023/20241.404 92 31 142 85 61 265 67 68 328 37 24 204
2024/2025650 13 18 16 321 282 0 0 0 0 0 0 0
Totale 14.358